Multiple Ascending Dose Safety Study of ShK-186 (Dalazatide) in Healthy Volunteers

NCT02446340 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: dalazatide
DRUG: placebo

Sponsor

Kineta Inc.